Geron’s Board of Directors believes that sound governance practices and policies are important for our success as a company and for ensuring alignment with our stockholders.

We are committed to ethical behavior by all of our employees, officers and directors. To promote ethical behavior, on December 27, 2022, Geron amended and restated its Code of Conduct (the “Amended Code of Conduct”). The Amended Code of Conduct is applicable to all employees, officers and directors of Geron. The Amended Code of Conduct replaces Geron’s previous Code of Conduct (the “Prior Code”) in its entirety, to, among other things, reflect current industry and public company best practices and enhance and expand on guiding principles and policies, including expanding provisions related to (i) compliance with health care laws and regulations, (ii) product quality, pharmacovigilance and regulatory compliance, and (iii) privacy and information security policies. The Amended Code of Conduct does not result in any waiver with respect to any officer, director or employee of Geron from any provision of the Prior Code as in effect prior to the amendment of the Prior Code.

Here we share with you our corporate governance guidelines, Amended Code of Conduct, Insider Trading Compliance Program, and charters of each of the Board Committees, along with a list of our current Board of Directors and the Board Committees on which they participate.

Stockholders wishing to contact Geron’s Board of Directors, may do so by writing c/o Stephen N. Rosenfield, Secretary, Geron Corporation, 919 E. Hillsdale, Suite 250, Foster City, CA 94404, or via email to Secretary@geron.com.

Governance documents

Download item year list

Committee charters

Download item year list
Date Download Description
October 5, 2019

Committee composition

Board diversity

Board Diversity Matrix for Geron Corporation
Total Number of Directors 8
Part I: Gender Identity Female Male Non-Binary Did Not Disclose Gender
Directors 4 4
Part II: Demographic Background
Did Not Disclose Demographic Background 8


In August 2021, Nasdaq amended its listing standards to encourage greater board diversity and to require board diversity disclosures for Nasdaq-listed companies. Named the Board Diversity Rule, it requires companies listed on the Nasdaq U.S. exchange to:

  1. Publicly disclose board-level diversity statistics using a standardized template; and
  2. Have or explain why they do not have at least two diverse directors.

The Board Diversity Rule also provides flexibility for Smaller Reporting Companies and Foreign Issuers, which can meet the diversity objective by including two female directors.

Geron meets the definition of a Smaller Reporting Company and thus, complies with the Nasdaq Board Diversity Rule by having more than two female directors (i.e., four).